
A California federal judge was asked on Thursday to approve $165 million in new settlement agreements with the makers of an electronic component to resolve civil price-fixing claims.
Plaintiffs’ lawyers representing direct purchasers said in a court filing that Nippon Chemi-Con and United Chemi-Con agreed to pay $160 million, and Matsuo Electric will pay $5 million, to resolve claims that they conspired to fix the prices of certain capacitors. Such components regulate currents in televisions, office equipment, mobile phones and other electronic devices.
The settlement plan was first announced in December on the eve of closing arguments in the companies’ trial in US District Court for the Northern District of California. U.S. District Judge James Donato will consider the proposed settlement at a hearing on May 5.
The new deals, adding to earlier settlements with other companies in the litigation, push the total amount of payments for direct purchase class members to more than $604 million.Lead counsel for the direct purchaser plaintiffs, Joseph Saveri of San Francisco’s Joseph Saveri Law Firm, did not immediately comment on Friday about the settlement.
In May 2018, Nippon pleaded guilty to conspiracy to fix prices during the period between November 2001 to January 2014. In total, eight companies and ten individuals were charged with criminal conspiracy in that case, with Nippon Chemi-Con being sentenced by the US Department of Justice to pay US$60 million fine.
The company was also given five years of probation in that case, during which it is required to implement an effective compliance program and submit annual reports
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas